Institute of Enzymology, Research Center for Natural Sciences, Hungarian Academy of Sciences, Karolina út 29, H-1113 Budapest, Hungary.
Biochem Biophys Res Commun. 2012 May 25;422(1):28-35. doi: 10.1016/j.bbrc.2012.04.088. Epub 2012 Apr 25.
Adipose tissue-derived stromal cells (ASCs) are increasingly being studied for their usefulness in regenerative medicine. However, limited life span and donor-dependent variation of primary cells such as ASCs present major hurdles to controlled and reproducible experiments. We therefore aimed to establish immortalized ASC cell lines that provide steady supply of homogeneous cells for in vitro work while retain essential features of primary cells. To this end, combinations of human telomerase reverse transcriptase (hTERT), murine Bmi-1, and SV40 large T antigen (SV40T) were introduced by lentiviral transduction into ASCs. The resulting cell lines ASC(hTERT), ASC(Bmi-1), ASC(Bmi-1+hTERT) and ASC(SV40T+hTERT) were tested for transgene expression, telomerase activity, surface immunomarkers, proliferation, osteogenic and adipogenic differentiation, karyotype, tumorigenicity, and cellular senescence. All cell lines have maintained expression of characteristic surface immunomarkers, and none was tumorigenic. However, ASC(Bmi-1) had limited replicative potential, while the rapidly proliferating ASC(SV40T+hTERT) acquired chromosomal aberrations, departed from MSC phenotype, and lost differentiation capacity. ASC(hTERT) and ASC(hTERT+Bmi-1), on the other hand, preserved all essential MSC features and did not senesce after 100 population doublings. Notably, a subpopulation of ASC(hTERT) also acquired aberrant karyotype and showed signs of transformation after long-term culture. In conclusion, hTERT alone was sufficient to extend the life span of human ASC, but ASC(hTERT) are prone to transformation during extensive subculturing. The combination of Bmi-1 and hTERT successfully immortalized human ASCs without significantly perturbing their phenotype or biological behavior.
脂肪组织来源的基质细胞(ASCs)越来越多地被研究用于再生医学。然而,原发性细胞(如 ASC)的有限寿命和供体依赖性变异性是控制和可重复实验的主要障碍。因此,我们旨在建立永生化的 ASC 细胞系,为体外工作提供稳定的同质细胞供应,同时保留原代细胞的基本特征。为此,我们通过慢病毒转导将人端粒酶逆转录酶(hTERT)、小鼠 Bmi-1 和 SV40 大 T 抗原(SV40T)组合引入 ASCs。通过转染得到的 ASC(hTERT)、ASC(Bmi-1)、ASC(Bmi-1+hTERT)和 ASC(SV40T+hTERT)细胞系,进行转基因表达、端粒酶活性、表面免疫标志物、增殖、成骨和脂肪分化、核型、致瘤性和细胞衰老检测。所有细胞系均保持特征性表面免疫标志物的表达,且均无致瘤性。然而,ASC(Bmi-1)的复制潜力有限,而快速增殖的 ASC(SV40T+hTERT)则获得了染色体异常,偏离了 MSC 表型,并丧失了分化能力。另一方面,ASC(hTERT)和 ASC(hTERT+Bmi-1)保留了所有 MSC 的基本特征,并且在 100 个细胞倍增后不会衰老。值得注意的是,ASC(hTERT)的一个亚群在长期培养后也获得了异常核型,并出现转化迹象。总之,单独使用 hTERT 就足以延长人 ASC 的寿命,但 ASC(hTERT)在广泛的传代培养中容易发生转化。Bmi-1 和 hTERT 的组合成功地永生化了人 ASC,而不会显著改变其表型或生物学行为。